Planned early birth for pregnant women with high blood pressure cuts maternal complications by nearly half and reduces the risk of stillbirth, without increasing the likelihood of caesarean section, according to a new Cochrane review.

Discover the role Cochrane Thailand has played in closing the gap between evidence and outcomes. Designated as a WHO Collaborating Centre for Research Synthesis in Reproductive Health, the group has not only generated Cochrane reviews but has also translated those findings into national policy and clinical guidelines.

Blood tests to detect potential signs of prostate cancer likely reduce the risk of dying from prostate cancer, an updated Cochrane review finds. This is a shift from the previous version of the review.

Cochrane has released a pre-print of the protocol for our innovative study that will test whether artificial intelligence (AI) tools can support or enhance evidence synthesis. Gerald Gartlehner from Cochrane Austria, Principal Investigator for the study, discusses how the study works, and what makes it interesting.

Drugs that target amyloid beta proteins in the brain likely have no clinically meaningful positive effects, while increasing the risk of bleeding and swelling in the brain, a new Cochrane review has found.

We seek nominations for one upcoming vacant position on the Cochrane Methods Executive, to start in September 2026. Please note the deadline for nominations is Friday, 29 May 2026.

Image Members of Cochrane Russia at a workshop in Kazan When Cochrane Russia was established in 2015, it began as a coordinating hub fo

A new Cochrane review finds that chlorhexidine likely cuts umbilical cord infection rates by about 29% in low- and middle- income countries, and may reduce newborn deaths.

The Cochrane Collaboration is delighted to announce that Rupa Sarkar starts today as the new Editor in Chief.

Cochrane is launching a new eight-part series of Cochrane Learning Live webinars designed to help systematic reviewers understand and apply the GRADE (Grading of Recommendations, Assessment, Development and Evaluation) framework in evaluating the certainty of evidence in their systematic reviews.

Cochrane has confirmed the two artificial intelligence (AI) tools selected to take part in our innovative platform study evaluating how artificial intelligence could support and enhance key stages of evidence synthesis.

Cochrane has launched an innovative study to test whether artificial intelligence tools can support or enhance evidence synthesis. We only have scope to evaluate two, and so a selection process was required. Here, we outline that process and demonstrate what Cochrane values when deciding whether to use an AI tool for evidence synthesis.

Over the past 10 years Cochrane Taiwan has built a reputation for mobilizing knowledge and promoting evidence-based medicine both in Taiwan and beyond. Here they share some of the successes and learnings that have stood out over the past decade.

We’re pleased to announce four recent improvements to RevMan that will help users to structure analyses more accurately, avoid common Summary of Findings (SoF) issues, and prepare complete synthesis PICOs.

We are delighted to announce the launch of the new Cochrane Thematic Group in Infectious Diseases.

As International Women’s Day is marked around the world, women in leadership roles across the evidence and health sectors are reflecting on their careers, lessons learned and what it means to ‘give’ as a leader.

A comprehensive new systematic review published in The Journal of Nutrition provides the latest evidence that large-scale food fortification is a highly cost-effective intervention for reducing global malnutrition.

A new Cochrane review has found that sucrose can help with pain relief in newborn babies during common hospital procedures, such as venepuncture. This involves drawing blood with a needle, typically for testing.

For many women, the career path is anything but linear. Barbara Miheso reflects on her journey in science, which has included instability, pauses for motherhood, moments of doubt, and quiet rebuilding. Discover her journey, and the lessons it taught her.

A new partnership between Cochrane’s publishing partner Wiley and the medical AI platform OpenEvidence will see Cochrane evidence helping to inform the platform’s users, including more than 40% of US physicians.